Recombinant CD40L (Ruplizumab Biosimilar) antibody (PE)

Catalog No. ABIN7867161

The Humanized Monoclonal anti-CD40L (Ruplizumab Biosimilar) antibody is suitable to detect CD40L (Ruplizumab Biosimilar) in samples from Human. It has been validated for FACS.

Quick Overview for Recombinant CD40L (Ruplizumab Biosimilar) antibody (PE) (ABIN7867161)

Target: CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CD40L (Ruplizumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-CD40L (Ruplizumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-CD40 Ligand (ruplizumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for CD40L (Ruplizumab Biosimilar)

Target: CD40L (Ruplizumab Biosimilar) (CD40LG (Ruplizumab Biosimilar))

Alternative Name: ruplizumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: CD40LG,CD154,CD40L,HIGM1,IGM,IMD3,T-BAM,TNFSF5,TRAP,gp39,BG-9588, hu5c8

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P29965